Open AccessType I Interferons in the Treatment of Pancreatic Cancer
Author(s) -
Giovanni Vitale,
Casper H.J. van Eijck,
Peter M. van Koetsveld Ing,
Joris I. Erdmann,
Ernst J. M. Speel,
Katy van der Wansem Ing,
Diana M. Mooij,
Annamaria Colao,
Gaetano Lombardi,
Ed Croze,
Steven W. J. Lamberts,
Leo J. Hofland
Publication year - 2007
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/01.sla.0000261460.07110.f2
Subject(s) - propidium iodide , apoptosis , medicine , cell cycle , cell growth , cell culture , cancer research , receptor , pancreatic cancer , microbiology and biotechnology , biology , cancer , programmed cell death , biochemistry , genetics
We evaluated the role of type I interferons (IFNs) and IFN receptors in the regulation of cell growth in 3 human pancreatic adenocarcinoma cell lines (BxPC-3, MiaPaCa-2, and Panc-1).